查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血液製品全球市場研究報告 - 2023-2030 年行業分析、規模、份額、增長、趨勢和預測
市場調查報告書
商品編碼
1264213

血液製品全球市場研究報告 - 2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Blood Products Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 105 Pages | 商品交期: 最快1-2個工作天內

價格

血液製品是指從人體血液中提取的任何藥物，包括全血、輸血用血液成分和血漿衍生藥物化合物。 每年，安全、有效和有質量保證的血液產品通過解決兒童死亡率和孕產婦健康這兩個最緊迫的問題來改善或挽救數百萬人的生命。 血液製品是從供體中提取供患者使用的血液成分或部分。 並非所有患者都需要完全輸血，通常只需要輸一些血液成分。 在這種情況下，從全血中提取特定的血液成分。 血液製品包括血小板、紅細胞（RBC）、白細胞（WBC）、新鮮冰凍血漿（FFP）、凝血因子等血液製品。 某些血液製品根據人的情況給予。

市場動態：

由於血液相關疾病的患病率上升以及對血液相關產品的需求增加，血液製品市場正在增長。 此外，血液製品市場受到不斷擴大的老年人口的推動。 同樣，提供測試試劑、篩選設備和系統以對捐獻的血液進行測試的重要市場參與者推動了血液製品市場。 此外，由於世界人口老齡化加劇以及政府對血液篩查的倡議和法規，預計血液製品市場將會增長。 促進市場迅速擴大的另一個方面是公眾對獻血的認識不斷提高。 此外，對血液和血漿的需求增加正在推動對血液製品的需求。 然而，增強血液採集的高成本和缺乏經驗豐富的實驗室人員限制了市場擴張。

研究報告描述了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還提供了對全球血液製品市場各個部分的全面評估。 血液製品行業的發展和趨勢為這項研究提供了一個整體的方法。

市場細分：

血液製品市場細分提供按國家和地區劃分的詳細數據，以幫助確定產品和服務的目標受眾和未來商機。

按產品類型

  • 血小板
  • 新鮮冰凍血漿 (FFP)
  • 紅細胞 (RBCS)
  • 白細胞 (WBCS)
  • 其他

按最終用途

  • 醫院
  • 血站
  • 其他

按地區分析：

本部分涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲血液製品市場當前和未來的需求。 此外，它還關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 血液製品市場的主要參與者有 CSL、Octapharma AG、Kedrion S.p.A、Mitsubishi Tanabe Pharma Corporation、BPL Inc. 等。 本節全面介紹了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

如果您有任何定制要求，請寫信給我們。 我們的研究團隊可以根據您的需要提供定制報告。

內容

第一章前言

  • 報告內容
    • 目的
    • 目標受眾
    • USP（獨特的銷售建議）及其提供的內容
  • 調查範圍
  • 調查方法
    • 市場調研流程
    • 市場研究方法

第 2 章執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章血液製品 - 行業分析

  • 簡介 - 市場動態
  • 市場驅動因素
  • 市場製約因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按產品類型
    • 按最終用途
    • 按地區

第四章價值鏈分析

  • 價值鏈分析
  • 原材料分析
    • 原材料清單
    • 原材料製造商名單
    • 主要原材料價格走勢
  • 潛在買家名單
  • 營銷渠道
    • 直接營銷
    • 間接營銷
    • 市場發展趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章血液製品的全球市場分析：按產品類型

  • 摘要：按產品類型
  • 過去和未來的數據
  • 分析：按產品類型
  • 血小板市場：按地區
  • 新鮮冷凍血漿 (FFP) 市場：按地區
  • 紅細胞 (RBC) 市場：按地區
  • 白細胞 (WBC) 市場：按地區
  • 其他市場：按地區

第 7 章全球血液製品市場最終用途分析

  • 按最終用途匯總
  • 過去和未來的數據
  • 最終用途分析
  • 醫院市場：區域細分
  • 血站市場：按地區
  • 其他市場：按地區

第 8 章全球血液製品市場分析：按地區

  • 區域展望
  • 簡介
  • 北美
    • 摘要、實際數據、預測數據
    • 按北美細分
    • 北美：按國家/地區列出
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 摘要、實際數據、預測數據
    • 歐洲（按細分市場）
    • 歐洲：按國家/地區分類
    • 英國
    • 法國
    • 德國
    • 意大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 摘要、實際數據、預測數據
    • 亞太區信息
    • 亞太地區：國家/地區信息
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
    • 其他亞太地區
  • 拉丁美洲
    • 摘要、實際數據、預測數據
    • 拉丁美洲細分市場
    • 拉丁美洲：按國家/地區列出
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲地區
  • 中東和非洲
    • 摘要、實際數據、預測數據
    • 中東和非洲分部信息
    • 中東和非洲：按國家/地區列出
    • 沙特阿拉伯
    • 阿聯酋
    • 以色列
    • 南非
    • 其他中東和非洲地區

第9章血液製品廠商的競爭格局

  • 血液製品的市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他擴展

第十章公司簡介

  • 公司股票分析
  • 市場集中度
  • 中超
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • Octapharma 公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • Kedrion S.p.A.
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • 田邊三菱製藥公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢
  • BPL 公司
    • 公司簡介
    • 產品介紹
    • 近期趨勢

注意：在公司簡介、財務細節、近期發展等方面，基於可用信息，私人控股公司可能不包括在內。

Product Code: VMR11217053

A blood product is any medicinal substance derived from human blood, such as whole blood and various blood components for transfusion and plasma-derived pharmaceutical compounds. Every year, safe, effective, and quality-assured blood products serve to improve and save millions of lives by addressing two pressing issues: child mortality and maternal health. A blood product is any component or part of blood extracted from a donor for use in patients. Not every patient requires a complete blood transfusion; many only require select blood components to be transfused. In such cases, specific blood components are extracted from the whole blood. Blood products include platelets, red blood cells (RBCs), white blood cells (WBCs), fresh frozen plasma (FFP), clotting factors, and other blood products. Depending on a person's condition, they are given a particular blood product.

Market Dynamics:

The market for blood products is growing due to the rising prevalence of blood-related ailments and the demand for blood-related goods. Furthermore, the market for blood products is being propelled ahead by the expanding older population. Again, significant market companies that provide reagents for testing, screening equipment, and systems to execute tests on donated blood are driving the blood product market. Furthermore, the blood products market is expected to grow as the global elderly population grows and government initiatives and regulations for blood screening. Another aspect contributing to the market's rapid expansion is increased public awareness regarding blood donation. Furthermore, increased demand for blood and plasma pushes demand for blood products. However, the high cost of enhanced blood collection and a scarcity of experienced laboratory personnel limit the market's expansion.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of blood products. The growth and trends of blood products industry provide a holistic approach to this study.

Market Segmentation:

This section of the blood products market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Platelets
  • Fresh Frozen Plasma (FFP)
  • Red Blood Cells (RBCS)
  • White Blood Cells (WBCS)
  • Others

By End-Use

  • Hospital
  • Blood Station
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Blood Products market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the blood products market include CSL, Octapharma AG, Kedrion S.p.A, Mitsubishi Tanabe Pharma Corporation, BPL Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . BLOOD PRODUCTS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Product Type
    • 3.7.2 By End-Use
    • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BLOOD PRODUCTS MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Platelets Market by Regions
  • 6.6 Fresh Frozen Plasma (FFP) Market by Regions
  • 6.5 Red Blood Cells (RBCs) Market by Regions
  • 6.7 White Blood Cells (WBCs) Market by Regions
  • 6.8 Others Market by Regions

7 . GLOBAL BLOOD PRODUCTS MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-Use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-Use
  • 7.4 Hospital Market by Regions
  • 7.5 Blood Station Market by Regions
  • 7.6 Others Market by Regions

8 . GLOBAL BLOOD PRODUCTS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview, Historic and Forecast Data
    • 8.3.2. North America By Segment
    • 8.3.3. North America By Country
    • 8.3.4. United State
    • 8.3.5. Canada
    • 8.3.6. Mexico
  • 8.4. Europe
    • 8.4.1. Overview, Historic and Forecast Data
    • 8.4.2. Europe by Segment
    • 8.4.3. Europe by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7. Italy
    • 8.4.8. Russia
    • 8.4.9. Rest Of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview, Historic and Forecast Data
    • 8.5.2. Asia Pacific by Segment
    • 8.5.3. Asia Pacific by Country
    • 8.5.4. China
    • 8.5.5. India
    • 8.5.6. Japan
    • 8.5.7. South Korea
    • 8.5.8. Australia
    • 8.5.9. Rest Of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview, Historic and Forecast Data
    • 8.6.2. Latin America by Segment
    • 8.6.3. Latin America by Country
    • 8.6.4. Brazil
    • 8.6.5. Argentina
    • 8.6.6. Peru
    • 8.6.7. Chile
    • 8.6.8. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview, Historic and Forecast Data
    • 8.7.2. Middle East & Africa by Segment
    • 8.7.3. Middle East & Africa by Country
    • 8.7.4. Saudi Arabia
    • 8.7.5. UAE
    • 8.7.6. Israel
    • 8.7.7. South Africa
    • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE BLOOD PRODUCTS COMPANIES

  • 9.1. Blood Products Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF BLOOD PRODUCTS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. CSL
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Octapharma AG
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Kedrion S.p.A.
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Mitsubishi Tanabe Pharma Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. BPL Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Product Type (USD MN)
  • Platelets Market by Geography (USD MN)
  • Fresh Frozen Plasma (FFP) Market by Geography (USD MN)
  • Red Blood Cells (RBCs) Market by Geography (USD MN)
  • White Blood Cells (WBCs) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by End-Use (USD MN)
  • Hospital Market by Geography (USD MN)
  • Blood Station Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Blood Products Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Blood Products Report
  • Market Research Process
  • Market Research Methodology
  • Global Blood Products Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Platelets Market by Geography (USD MN)
  • Fresh Frozen Plasma (FFP) Market by Geography (USD MN)
  • Red Blood Cells (RBCs) Market by Geography (USD MN)
  • White Blood Cells (WBCs) Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospital Market by Geography (USD MN)
  • Blood Station Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.